Details of the Drug Formulation (DFM)
General Information of DFM (ID: F02791) | |||||
---|---|---|---|---|---|
Name |
Bupropion 522 mg tablet
|
||||
Company |
Sanofi-Aventis
|
||||
Active Pharmaceutical Ingredient (API) | Bupropion |
API Info
![]() |
|||
Nicotine dependence | ICD-11: 6C4A | Approved | |||
Drug Inactive Ingredient (DIGs) | |||||
DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
E07UZH | DIG Info | Dibutyl sebacate | Plasticizing agent | ||
E0EI2M | DIG Info | Glyceryl dibehenate | Binding agent ... | ||
E0V3ER | DIG Info | Polyvinyl alcohol | Coating agent ... | ||
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Cytochrome P450 2E1 (CYP2E1) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Polyvinyl alcohol | |||||
Biological Activity | IC50 = 548.9 uM (tested by experiment) | [1] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2E1_HUMAN | |||||
DBT Name: Debrisoquine 4-hydroxylase (CYP2D6) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Polyvinyl alcohol | |||||
Biological Activity | EC50 = 354.8 uM (tested by experiment) | [1] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2D6_HUMAN | |||||
References | |||||
---|---|---|---|---|---|
1 | Mediation of in vitro cytochrome p450 activity by common pharmaceutical excipients. Mol Pharm. 2013 Jul 1;10(7):2739-48. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.